Recent advances in tuberculosis treatment: Towards shorter, safer, and more effective therapies. [PDF]
Timboe K, Jackson JB, Becker GL.
europepmc +1 more source
Side Effects of First-Line Anti-tubercular Therapy (ATT): Does an Alternative Regimen Exist? [PDF]
Goswami G +5 more
europepmc +1 more source
Anti-Tubercular Drug-Induced Liver Injury: Current Understanding and Emerging Directions. [PDF]
Prasad S, Narang H, Kedia S, Ahuja V.
europepmc +1 more source
Pre-extensively drug-resistant tuberculosis of the spine in a previously healthy young adult: case report. [PDF]
Schreurs H +5 more
europepmc +1 more source
Population pharmacokinetics model of pyrazinamide to optimize tuberculosis treatment: An interethnic cohort study of diabetes mellitus effect on drug exposure. [PDF]
Jayanti RP +19 more
europepmc +1 more source
Analysis of factors influencing plasma concentrations of anti-TB drugs in pediatric TB patients. [PDF]
Huang Y +5 more
europepmc +1 more source
Plasma and CSF pharmacokinetic characteristics of second-line anti-tuberculosis drugs in a patient with multidrug-resistant tuberculous meningitis. [PDF]
Gao J +6 more
europepmc +1 more source
<i>Mycobacterium tuberculosis</i> growth arrest on propionate at acidic pH is suppressed by mutations in <i>phoPR</i> and pyrazinamide treatment. [PDF]
Murdoch HM +3 more
europepmc +1 more source
Bedaquiline and levofloxacin replacing rifampicin for the treatment of TB. [PDF]
Chiang CY, Bai KJ, Yu MC.
europepmc +1 more source
Case Report: Clinical characteristics and multidisciplinary collaborative management of congenital tuberculosis in extremely preterm twins and preterm infants: a report of three cases and literature review. [PDF]
Yang L, Yue L, Chen Q, Huang X.
europepmc +1 more source

